Advanced search
Start date
Betweenand


Quality of life and psychosocial adjustment of patients with type 1 diabetes mellitus who underwent hematopoietic stem cell transplantation: A follow-up study.

Full text
Author(s):
Letícia Aparecida da Silva Marques
Total Authors: 1
Document type: Master's Dissertation
Press: Ribeirão Preto.
Institution: Universidade de São Paulo (USP). Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto (PCARP/BC)
Defense date:
Examining board members:
Manoel Antonio dos Santos; Marilda Emmanuel Novaes Lipp; Carla Regina de Souza Teixeira
Advisor: Manoel Antonio dos Santos
Abstract

Transplantation of hematopoietic stem cells has emerged as an alternative to the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes mellitus. In the latter, a syndrome of multiple etiology, the hematopoietic stem cell transplantation, in its autologous method, has been used as an alternative to conventional treatment (therapy with insulin), once it slows, but does not eliminate the consequences of the disease such as dysfunction and failure of various organs, especially kidneys, eyes, nerves, heart and blood vessels. Nevertheless, transplantation is a highly invasive procedure that carries severe repercussions on the quality of life of these patients, requiring from them a readjustment to these repercussions. The present study aimed to evaluate the quality of life and psychosocial adjustment of participants with type 1 diabetes mellitus. The study included 22 patients who underwent consecutive hematopoietic stem cell transplantation in the Bone Marrow Transplantation Ward of the Hospital das Clinicas of the University of Sao Paulo at Ribeirao Preto Medical School, between 2006 and 2008. The following instruments were used for data collection: Medical Outcomes Study 36 Item Short-Form Health Survey (SF-36), Hospital Anxiety and Depression Scale (HAD) and Lipp Stress Symptoms Inventory for Adults (LSSI). Assessments were performed at three different moments: at patient admission, one year after the performance of the procedure and two years after transplantation at the post-transplant outpatient clinic. Analysis of the instruments was done according to specific recommendations proposed in the literature. Results showed that, for most participants of the study, one year after the procedure, the indices of quality of life improved significantly, mainly the domains Physical Functioning (p=0.0003), General Health (p=0.0142), Social Functioning (p=0.0018) and Role-Emotional (p=0.0316). After two years, the transplant also had a positive impact on the quality of life, especially in the domains Physical Functioning (p<0.0001), Social Functioning (p=0.0235) and Role-Emotional (p=0.0270). In relation to psychosocial adjustment, results showed a reduction in symptoms of anxiety after the first year of transplantation (p<0.01) and depression at the two moments after transplantation (p<0.01). A decrease in symptoms of stress at the studied moments (p <0.01) was also observed. These results may represent a possibility of renewed life and future plans that were interrupted by a chronic illness that imposed inevitable difficulties and limitations to these participants. Results of this study provide support to the multidisciplinary health team reflect on the implications of this innovative therapy in essential aspects of participants life that go beyond the biomedical dimension, considering the repercussions on their quality of life and psychosocial adjustment. (AU)

FAPESP's process: 10/03015-0 - Quality of life of patients with type 1 diabetes mellitus submetted transplantation of hematopoietic stem cells: a longitudinal study
Grantee:Leticia Aparecida da Silva Marques
Support Opportunities: Scholarships in Brazil - Master